Biology Reference
In-Depth Information
elevation myocardial infarction: REVEAL: a
randomized controlled trial. JAMA 305(18):
1863-1872
66. Ferrario M, Arbustini E, Massa M, Rosti V,
Marziliano N, Raineri C, Campanelli R,
Bertoletti A, De Ferrari GM, Klersy C, Angoli
L, Bramucci E, Marinoni B, Ferlini M, Moretti
E, Raisaro A, Repetto A, Schwartz PJ, Tavazzi
L (2011) High-dose erythropoietin in patients
with acute myocardial infarction: a pilot, ran-
domised, placebo-controlled study. Int J
Cardiol 147(1):124-131
67. Andreotti F, Agati L, Conti E, Santucci E, Rio
T, Tarantino F, Natale L, Berardi D, Mattatelli
A, Musumeci B, Bonomo L, Volpe M, Crea F,
Autore C (2009) Update on phase II studies
of erythropoietin in acute myocardial infarc-
tion. Rationale and design of Exogenous
erythroPoietin in Acute Myocardial Infarction:
New Outlook aNd Dose Association Study
(EPAMINONDAS). J Thromb Thrombolysis
28(4):489-495
68. Ahmet I, Lakatta EG, Talan MI (2011)
Therapeutic window for cardioprotection by
recombinant human erythropoietin (rhEPO)
in the rat model of ischemia-reperfusion: impli-
cations for clinical trial design. AHA 2011,
Abstract
Search WWH ::
Custom Search